For the study, the expression changes of EGFR, P-EGFR, ERK1/2 and P-ERK1/2, the related molecules in the EGFR-TK signal transduction pathway were measured to investigate the binding and regulatory relationship between 3l and EGFR in cancer cells (Chen et al., 2019). The gene discussed is TKT; the disease is cancer.